Aggressive Diabetes Treatment and Death Risk
Filed in archive Research , Treatment by Gloria Gamat on February 08, 2008

Most especially in those with type 2 diabetes that also have heart disease or multiple risk factors for heart disease - putting them in an in an increased risk of dying.
Researchers had to curtail a major clinical trial of intensive treatment for such patients after concluding that patients with the lowest blood sugar levels had an increased risk of dying compared with those with a more modest reduction of sugar levels.
The findings were a surprise to researchers, who expected to see a clear benefit from the lower sugar levels, and their source remains a mystery. Analysis has been unable to link the increased death rate to episodes of hypoglycemia- low blood sugar - or to any drug or combination of drugs used in the study.
In particular, researchers did not find any link to the diabetes drug rosiglitazone, trade-named Avandia, which has previously been linked to deaths from heart disease among those taking it.
Intensive blood sugar-lowering treatments included in this study pertains to conventional blood sugar-lowering drugs (with lifestyle modifications) on high doses and multiple combinations.
Find more details from the L.A. Times.
Permalink: Aggressive Diabetes Treatment and Death Risk
Tags:
blood sugarlowering hypoglycemia type 2 diabetes
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/113126










